4//SEC Filing
ALNYLAM PHARMACEUTICALS, INC. 4
Accession 0001325812-16-000110
$ALNYCIK 0001178670operating
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:20 PM ET
Size
5.7 KB
Accession
0001325812-16-000110
Insider Transaction Report
Form 4
Gros David-Alexandre C
SVP, Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2016-12-20+25,000→ 25,000 totalExercise: $42.22Exp: 2026-12-20→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]Represents the time-vested portion of the reporting person's 2016 Annual Stock Option award. The reporting person also received an option to purchase 25,000 shares of ALNY common stock that will vest upon the achievement of four specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests.
- [F2]The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeoperating
Related Parties
1- filerCIK 0001178670
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:20 PM ET
- Size
- 5.7 KB